Guertin, J. et al. 2018. IMPACT OF A RESTRICTIVE DRUG ACCESS PROGRAM ON THE RISK OF CARDIOVASCULAR ENCOUNTERS IN CHILDREN EXPOSED TO ADHD MEDICATIONS. Journal of Population Therapeutics and Clinical Pharmacology. 21, 3 (Nov. 2018).